Liverpool Ocular Oncology<br />Research Group
 
  • HOME
  • NEWS
  • Research Team
  • Disease Focus and Research
    • Uveal Melanoma
    • Conjunctival melanoma
    • Ocular Adnexal Lymphoma
  • Molecular Pathology
  • Ocular Oncology Biobank (OOB)
  • Paper Publications
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
  • Book Chapters
  • Informative Videos
  • Alumni
    • Previous Staff
    • Past PhD Students
    • Past MD Students
    • Past MRes Students
    • Past BSc/MSc Students
    • Nuffield Students
  • Visitors
    • Visiting researchers and clinicians
    • Visiting Students
  • Support Us/Donations
  • Fundraising Events
  • Training and Opportunities
  • Contact us
  • Links
Picture
2005

Coupland SE, Hummel M, Stein H (2005)
Molecular analysis of immunoglobulin genes in primary intraocular lymphoma. Invest Ophthalmol Vis Sci,46(10),pp.3507-3514

 Coupland SE, Loddenkemper C, Charlotte F, Smith JR, Hummel M, Stein H (2005) Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma. Invest Ophthalmol Vis Sci,46(11),pp.3957-3964 

Jahnke K, Coupland SE, Na IK , Loddenkemper C, Thiel E, Keilholz U, Scheibenbogen C (2005) Expression of the chemokine receptors CXCR4, CXCR5 and CCR7 in primary central nervous system lymphoma. Blood,106(1),pp.384-385 

Hughes S, Damato BE, Giddings I, Hiscott PS, Humphreys J, Houlston RS. Microarray comparative genomic hybridisation analysis of intraocular uveal melanomas identifies distinctive imbalances associated with loss of chromosome 3. Br J Cancer. 2005; 93: 1191-6.

Jose Luis Ordonez, Luminita Paraoan, Paul Hiscott, Donna Gray, Ian Grierson, Bertil Damato. Differential expression of angioregulatory matricellular proteins in posterior uveal melanoma. Melanoma Research 2005; 15: 495-502.

Purbrick RMJ, Tu KL, Damato B. The patient's role in the decision-making process - a perspective from the Liverpool Ocular Oncology Centre. Eye. 2005. (Epub ahead of print).

Damato B, Kacperek A, Chopra M, Campbell IR, Errington RD. Proton beam radiotherapy of iris melanoma. International Journal of Radiation Oncology*Biology*Physics. 2005; 63: 109-15. The first reported series.

Damato B, Kacperek A, Chopra M, Campbell IR, Errington RD. Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge Experience. International Journal of Radiation Oncology*Biology*Physics 2005; 62: 1405-11.

Damato B, Patel I, Campbell IR, Mayles H, Errington RD. Local tumor control after 106 brachytherapy of choroidal melanoma. International Journal of Radiation Oncology*Biology*Physics. 2005. 63; 385-391. The first paper on brachytherapy to report eccentric plaque positioning.

Damato B, Patel I, Campbell IR, Mayles H, Errington RD. Damato B, Patel I, Campbell IR, Mayles H, Errington RD. Visual acuity after ruthenium 106 brachytherapy of choroidal melanomas. International Journal of Radiation Oncology*Biology*Physics. 2005. 63; 392-400.

Ross JJ, Tu L, Damato B. Systemic remission of non-Hodgkin's lymphoma after intralesional interferon alpha-2b to bilateral conjunctival lymphomas. Am J Ophthalmol. 2004 Oct;138(4):672-3

Spendlove HE, Damato B, Humphreys H , Hiscott PS, Houlston RS. BRAF mutations are detectable in conjunctival but not intra-ocular uveal melanomas. Melanoma Research. 2004; 14: 449-52.

Damato B, Jones A. Uveal melanoma: resection techniques. Clinics of North America. 2005; 18: 119-28.
Powered by Create your own unique website with customizable templates.